About Procognia
Procognia is a company based in Rehovot (Israel) founded in 2000. Procognia has raised $23.76 million across 1 funding round from investors including Apax Partners, Star Ventures and Evergreen-Partners. Procognia offers products and services including Antibodies, Devices, ELISA Kits, NATtrol, and Medium & Serums. Procognia operates in a competitive market with competitors including Medeloop, Find Therapeutics, Pure Biologics, Hyku Biosciences and Sirion Biotech, among others.
- Headquarter Rehovot, Israel
- Stage Public
- SectorsHealthcare
- Website procognia.com
- Social LinkedIn
- Total Equity Funding$23.76M (USD)
in 1 rounds
- Latest Funding Round$23.76M (USD), Series A
Nov 2004
- InvestorsApax Partners
& 2 more
Products & Services of Procognia
Procognia offers a comprehensive portfolio of products and services, including Antibodies, Devices, ELISA Kits, NATtrol, and Medium & Serums.
Products for detecting proteins in biological samples.
Equipment for proteomic and mass spectrometry analysis.
Kits for enzyme-linked immunosorbent assays in research.
Products for nucleic acid testing in viral studies.
Substances used for cell culture and sample preparation.
Funding Insights of Procognia
Procognia has successfully raised a total of $23.76M through 1 strategic funding round. The most recent funding activity was a Series A round of $23.76 million completed in November 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $23.76M
- Total Rounds 1
- Last Round Series A — $23.76M
- First Round $23.76M
(Nov 2004)
- Investors Count 3
All 1 funding rounds of Procognia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2004 | $23.76M | Series A | – | – |
3 investors in total: 3 institutional.
Investors in Procognia
Procognia has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Apax Partners, Star Ventures and Evergreen-Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Equity investments are focused on tech, services, and consumer sectors. | 1981 | apax.com | Hong Kong, China | |
Early & late stage sector-agnostic VC firm investing in the US, Asia and Middle East | – | star-ventures.com | Herzliya, Israel | |
Provides comprehensive services in advertising, digital media, and capital funding solutions. | 2004 | evergreen-partners.com | New York, United States |
Investor details for Procognia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Procognia
3 dated milestones of Procognia across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Procognia is founded.
- Funding First funding round of $23.8M.
- IPO Lists on the stock exchange (IPO).
Competitors of Procognia
Procognia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medeloop, Find Therapeutics, Pure Biologics, Hyku Biosciences and Sirion Biotech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medeloop.ai | 2021 | Palo Alto, United States | $23.5M | – | Drug discovery services are offered by Medeloop as a CRO. | |
| findtherapeutics.com | 2017 | – | $8.1M | – | Developer of precision targeted therapies for autoimmune diseases | |
| purebiologics.com | 2010 | Wroclaw, Poland | $2.6M | – | Specialized CRO with expertise in recombinant protein production and purification | |
| hykubiosciences.com | 2023 | Lexington, United States | $56M | – | Covalent medicines platform is advanced for drug discovery targeting proteins. | |
| sirion-biotech.com | 2005 | Planegg, Germany | – | 42 | Customized AAV-based viral vectors for gene therapy are supplied. | |
| centivax.com | 2019 | San Francisco, United States | $55M | – | Drug discovery services are provided to pharmaceutical and biotech clients. | |
| biointron.com | 2012 | Taizhou, China | – | – | Antibody-drug research and development services are provided. | |
| metagentx.com | 2020 | Tokyo, Japan | $15.72M | – | CRO focused on providing microbiome drug discovery and development services | |
| sanyoubio.com | 2015 | Shanghai, China | – | – | CRO focused on providing cell and molecular biology services for antibody drug discovery | |
| biolexistx.com | 2021 | Salt Lake, United States | $12.5M | – | CRO focused on drug discovery of small molecule therapeutics |
Detailed competitors of Procognia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Procognia
Complete news archive for Procognia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Procognia
10 companies that operate in the same segment as Procognia (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Procognia
Procognia was founded in 2000 and raised its 1st funding round 4 years after it was founded.
Procognia is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
Procognia is a funded company, having raised a total of $23.76M across 1 funding round to date. The company's 1st funding round was a Series A of $23.76M, raised on Nov 2004.
Procognia was founded in 2000 in Rehovot, Israel, within the biotechnology sector. Contract research services centered on glycosylation and protein function studies were offered to biopharmaceutical firms. Protein microarray technology was used for glycosylation analysis in drug discovery processes. An ongoing partnership with Teva was established, and Sense Proteomic was acquired in January 2003 to broaden the service offerings. The company has since been deadpooled.
Procognia's top competitors include Medeloop, Pure Biologics and Find Therapeutics.
Procognia offers Antibodies, Devices, ELISA Kits, NATtrol, and Medium & Serums.
Procognia has 3 investors. Key investors include Apax Partners, Star Ventures, and Evergreen-Partners.